Nahum Sonenberg /channels/taxonomy/term/9497/all en Viruses can ‘hijack’ cellular process to block immune response /channels/channels/news/viruses-can-hijack-cellular-process-block-immune-response-328652 <p>Research led by ϲ University and Queen’s University Belfast has found that viruses can ‘hijack’ an existing molecular process in the cell in order to block the body’s antiviral immune response to a viral infection.</p> <p>The results of the study have been published in the journal <a href="https://www.cell.com/molecular-cell/fulltext/S1097-2765(21)00050-2"><em>Molecular Cell</em></a><em>.</em></p> Wed, 17 Feb 2021 18:15:57 +0000 webfull 167976 at /channels New use for an old drug: How does ketamine combat depression? /channels/channels/news/new-use-old-drug-how-does-ketamine-combat-depression-327092 <p>A group of proteins called 4E-BPs, involved in memory formation, is the key to unlocking the antidepressant effect of ketamine in the brain, according to researchers from three Canadian universities. The <a href="https://www.nature.com/articles/s41586-020-03047-0">discovery</a> could lead to better and safer treatments for certain patients suffering from major depression.</p> Wed, 16 Dec 2020 16:07:12 +0000 webfull 166245 at /channels Two ϲ professors lead new Stand Up to Cancer Canada Metastatic Breast Cancer Dream Team /channels/channels/news/two-mcgill-professors-lead-new-stand-cancer-canada-metastatic-breast-cancer-dream-team-299423 <p>Marc Miller, Member of Parliament (Ville-Marie–Le Sud-Ouest–Île-des-Sœurs, Quebec) and Parliamentary Secretary to the Minister of Crown-Indigenous Relations, on behalf of the Honourable Ginette Petitpas Taylor, Minister of Health, announced today at ϲ an investment of up to $6 million for a scientific task force of top researchers to develop new and improved approaches to cancer treatment and care. The funding will be distributed over four years to the new pan-Canadian program, the Stand Up to Cancer (SU2C) Canada Metastatic Breast Cancer Dream Team.</p> Mon, 12 Aug 2019 14:31:53 +0000 webfull 151756 at /channels Nahum Sonenberg honoured with a Prix du Québec /channels/channels/news/nahum-sonenberg-honoured-prix-du-quebec-291906 <p>By Jason Clement</p> <p>“My father, who inspired me very much, would tell me ‘You must study and make a contribution to science’,” says renowned ϲ Professor Nahum Sonenberg reflecting back beyond the beginning of his remarkable career. “My exact career path of course I couldn’t predict, but I knew that I wanted to better understand how the human body works, how to cure disease, and that’s what I’m doing.”</p> Thu, 22 Nov 2018 12:39:15 +0000 webfull 143475 at /channels Canadian brain bank network to advance research on Alzheimer’s disease /channels/channels/news/canadian-brain-bank-network-advance-research-alzheimers-disease-284099 <p>More than 400,000 Canadians aged 65 and over live with diagnosed dementia, including Alzheimer’s disease, which accounts for approximately 70 percent of cases. The cause of this degenerative brain disease is largely unknown and no effective treatment exists. The disease has a devastating effect on individuals and their families.</p> Tue, 23 Jan 2018 18:53:20 +0000 webfull 134353 at /channels Nahum Sonenberg awarded prestigious Wolf Prize /channels/news/nahum-sonenberg-awarded-prestigious-wolf-prize-232487 <p>Nahum Sonenberg, a James ϲ Professor in the Department of Biochemistry and the Rosalind and Morris Goodman Cancer Research Centre at ϲ University, is one of eight winners of the prestigious Wolf Prize as announced in Tel Aviv yesterday. Fri, 17 Jan 2014 21:34:04 +0000 webfull 100741 at /channels Fragile X study offers hope of new autism treatment /channels/news/fragile-x-study-offers-hope-new-autism-treatment-240447 <p>People affected by a common inherited form of autism could be helped by a drug that is being tested as a treatment for cancer, according to researchers from the University of Edinburgh and ϲ University. Thu, 27 Nov 2014 18:47:02 +0000 webfull 106820 at /channels Finding the body clock’s molecular reset button /channels/news/finding-body-clock%E2%80%99s-molecular-reset-button-248699 <p> </p> <p>An international team of scientists has discovered what amounts to a molecular reset button for our internal body clock. Their findings reveal a potential target to treat a range of disorders, from sleep disturbances to other behavioral, cognitive, and metabolic abnormalities, commonly associated with jet lag, shift work and exposure to light at night, as well as with neuropsychiatric conditions such as depression and autism.</p> Mon, 27 Apr 2015 15:11:38 +0000 webfull 109735 at /channels Goodman Cancer Research Gala raises $2.1 million /channels/news/goodman-cancer-research-gala-raises-21-million-261149 <p><a href="/newsroom"><em><strong>ϲ Newsroom</strong></em></a></p> <p><em>Pioneering research at ϲ’s Goodman Cancer Research Centre gets boost</em></p> <p>The 4th Goodman Cancer Research Gala has raised more than $2.1 million to fund foundational research, more effective diagnostic tools and the development of new treatments and therapies for cancer patients.  The Gala was held on Sunday, June 5 in Montreal, bringing together more than 800 guests in support of ϲ University’s Rosalind and Morris Goodman Cancer Research Centre.</p> Mon, 06 Jun 2016 18:33:50 +0000 webfull 119168 at /channels New hope for understanding autism spectrum disorders /channels/news/new-hope-understanding-autism-spectrum-disorders-219071 <p><span>Researchers from ϲ University and the University of Montreal have identified a crucial link between protein synthesis and autism spectrum disorders (ASD), which can bolster new therapeutic avenues. Regulation of protein synthesis, also termed mRNA translation, is the process by which cells manufacture proteins. This mechanism is involved in all aspects of cell and organism function. A new study in mice has found that abnormally high synthesis of a group of neuronal proteins called neuroligins results in symptoms similar to those diagnosed in ASD. The study also reveals that autism-like behaviors can be rectified in adult mice with compounds inhibiting protein synthesis, or with gene-therapy targeting neuroligins. Their results are published in the journal </span><span><i>Nature</i></span><span>.</span> Wed, 21 Nov 2012 18:00:44 +0000 webfull 88621 at /channels